SecBot SecBot
SECBOTREPLAY Home › Report › EW

EW · Three Edwards Lifesciences insiders, including the CEO and a CVP, sold…

Edwards Lifesciences Corp · CLUSTER filed Nov 10, 2026 at 16:52 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Nov 10, 2026 at 16:52 ET

Three Edwards Lifesciences insiders, including the CEO and a CVP, sold a total of $6.05M in open-market sales under 10b5-1 plans. The sales follow a strong Q3 earnings beat and raised guidance reported six days earlier. The dollar value is modest relative to the company's market cap, and the 10b5-1 plans indicate pre-arranged trading, reducing the signal.

  • CEO Bernard Zovighian sold 23,100 shares (total $2.38M) under a 10b5-1 plan on Nov 9, 2026
  • CVP Donald Bobo sold 48,900 shares ($5.04M) under a 10b5-1 plan on Nov 9, 2026
  • CVP Daniel Lippis sold 619 shares ($65K) under a 10b5-1 plan on Nov 10, 2026
  • Total open-market sales: $6.05M, all under 10b5-1 plans

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access